Test ID: C5DCU
C5-DC Acylcarnitine, Quantitative, Urine
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Evaluation of patients with an abnormal newborn screen showing elevations of C5-DC
Diagnosis of glutaric aciduria type 1 deficiency
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Evaluation of patients with an abnormal newborn screen showing elevations of C5-DC. The results are not informative when patient is receiving L-carnitine supplements.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Flow Injection Analysis-Tandem Mass Spectrometry (FIA-MS/MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
C5-DC Acylcarnitine, QN, U
Aliases Lists additional common names for a test, as an aid in searching
Acylcarnitines, urine
GA 1
GA1
GCDH (Glutaryl-CoA Dehydrogenase) Deficiency
Glutaric Aciduria 1 (GA1) (GA 1)
Glutaric Aciduria Type 1
Glutaryl-CoA Dehydrogenase (GCDH) Deficiency
GAI
GA I
Glutarylcamitine
GA 1
GA1
GCDH (Glutaryl-CoA Dehydrogenase) Deficiency
Glutaric Aciduria 1 (GA1) (GA 1)
Glutaric Aciduria Type 1
Glutaryl-CoA Dehydrogenase (GCDH) Deficiency
GAI
GA I
Glutarylcamitine
External
link
PDF
document
Excel
document
Word
document